title: Fludarabine-induced bradycardia in a patient with refractory leukemia.
authors.forename: Woei
authors.initials: W
authors.lastname: Chung-Lo
authors.forename: Ching-Yun
authors.initials: CY
authors.lastname: Hsieh
authors.forename: Chang-Fang
authors.initials: CF
authors.lastname: Chiu
authors.forename: Li-Yuan
authors.initials: LY
authors.lastname: Bai
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000009:adverse effects; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001919:Bradycardia / Q000139:chemically induced*; D003561:Cytarabine / Q000009:adverse effects; D006801:Humans; D015255:Idarubicin / Q000009:adverse effects; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D016879:Salvage Therapy; D017211:Treatment Failure; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives*; D055815:Young Adult
chemical_list: D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D003561:Cytarabine; D014740:Vidarabine; C024352:fludarabine; D015255:Idarubicin